Diagnostic testing for Helicobacter pylori infection in pediatric patients suspected to have active H pylori infection and/or monitoring response to therapy.
Breath Kit
Breath Kit (1)
None
None
Fast 1HR prior and see instructions for kit collection (PTs 3-17 years)
Useful for the detection and quantification of hepatitis B virus (HBV) DNA in serum of patients with chronic HBV infection (ie, hepatitis B surface antigen-positive) and for monitoring disease progression in chronic HBV infection and response to anti-HBV therapy.
Plasma
EDTA (2)
None
None
Pour off plasma within 6 hours of collection. Dedicated 3.0mL plasma sample required.
REFRIGERATE (3 Days)
6 Days
PCR
87517
HBV DNA, HBV PCR, HBV Quantification, HBV DNA Quantitation, HBV Viral load, Hepatitis B Viral Load, Hepatitis B Quantitation, Hep B
Useful in monitoring patients with treated epithelial ovarian cancer for recurrence or progression. This test should not be used as a screening test for ovarian cancer.
Useful for establishing or confirming the clinical diagnosis of hereditary hemochromatosis (HH) in adults, for testing of individuals with increased transferrin-iron saturation in serum and serum ferritin. With appropriate genetic counseling, can be used as predictive testing of individuals who have a family history of HH. HFE genetic testing is NOT recommended for population screening.
Whole Blood
EDTA (1)
None
Green (1) Sodium Heparin -or- Yellow ACD (1)
RT
13 Days
Fluorescent Restriction Fragment Length Polymorphism - Polymerase Chain Reaction (PCR)
Useful when distinguishing large deletional hereditary persistence of fetal hemoglobin from other conditions with increased percentage of fetal hemoglobin, and when determining the distribution of Hb F within red blood cells.
Whole Blood
EDTA (1)
None
None
REFRIGERATE (7 Days)
6 Days
Flow Cytometry
88184
Acid Elution Test for Fetal Hgb, Fetal Hemoglobin, Hemoglobin F Red Cell Distribution, Hemoglobin-F Distribution
Useful as a screening tool to confirm a hematologic disorder, detect an unsuspected hematologic disorder, and/or monitor effects of radiation or chemotherapy.
Whole Blood
EDTA (1)
None
None
REFRIGERATE (48 Hours)
Photometry and hemoglobinometry
85027
CBC with Manual Differential, CBC Manual Diff, CBC without differential
Useful for determining hepatitis C virus (HCV) genotype (1 to 5) to guide antiviral therapy in patients with chronic hepatitis C, and for differentiating between HCV subtypes 1a and 1b. Should be performed only on specimens obtained from patients confirmed to have HCV RNA levels in serum of 500 IU/mL or higher.
Plasma
EDTA (2)
Serum
Red (2)
Pour off within 6 HR and freeze. Dedicated specimens required.
Useful for measuring heparin concentration in patients treated with low-molecular-weight heparin preparations, in the presence of prolonged baseline activated partial thromboplastin time (APTT), and when unfractionated heparin dose needed to achieve desired APTT prolongation is higher than expected.
Useful for the diagnosis of recent or past hepatitis B infection and the determination of occult hepatitis B infection in otherwise healthy hepatitis B virus (HBV) carriers with negative test results for hepatitis B surface antigen, anti-hepatitis B surface, anti-hepatitis B core IgM, hepatitis Be antigen, and anti-HBe.
Serum
SST (1)
Plasma
EDTA (1)
REFRIGERATE (5 Days)
4 Days
Chemiluminescence
86704
Hep B Core Ab, HBC, HBCAB, Anti-Hepatitis Bc, Antibody to Hepatitis Bc, Hepatitis B Virus (HBV), Hepatitis Bc
Useful for determining infectivity of hepatitis B virus (HBV) carriers, for monitoring infection status of chronically HBV-infected patients, and for monitoring serologic response of chronically HBV-infected patients who are receiving antiviral therapy.
Serum
SST (1)
Plasma
Green (1) Lithium Heparin
REFRIGERATE (6 Days)
Enzyme immunoassay
86705
Hep B Core Ab, HBC, HBCAB, Anti-Hepatitis Bc, Antibody to Hepatitis Bc, Hepatitis B Virus (HBV), Hepatitis Bc
Useful for determining infectivity of hepatitis B virus (HBV) carriers, monitoring infection status of individuals with chronic hepatitis B, monitoring serologic response of chronically HBV-infected patients receiving antiviral therapy, and for determining the level of hepatitis B e-antibody.
Useful for determining infectivity of hepatitis B virus (HBV) carriers, monitoring infection status of individuals with chronic hepatitis B, monitoring serologic response of chronically HBV-infected patients receiving antiviral therapy, and for determining the level of hepatitis B e-antigen.
Useful for the detection and identification of codon substitutions in the hepatitis C virus (HCV) NS5A genomic region that confer resistance to current direct-acting antiviral (DAA) drugs used for treatment of chronic hepatitis C infection due to HCV genotype 1a, 1b, or 3 (any subtype). Also useful in guiding initiation or change of antiviral drug combinations for the treatment of chronic HCV infection.
Useful for the diagnosis of recent or chronic hepatitis C virus infection in symptomatic patients. It is not offered as a screening or confirmatory test for hepatitis C virus (HCV) for blood, human cells, or tissue donors.
Plasma
EDTA (2)
Serum
Red (2)
Pour off within 6 HR and freeze. Dedicated specimens required.
Useful for detection of hepatitis D virus (HDV)-specific total antibodies (combined IgG and IgM) in human serum, for diagnosis of concurrent HDV infection in patients with acute hepatitis B virus (HBV) infection (acute coinfection), for diagnosis of chronic HBV infection (chronic coinfection), or for acute exacerbation of known chronic HBV infection (HDV superinfection).
Serum
SST (1)
Plasma
EDTA (1)
Pour off within 2 HR and freeze.
FREEZE
8 Days
Enzyme Immunoassay
86692 RUO
AHDV, Anti-HDV, Delta hepatitis, HDV, Hepatitis D, Hepatitis D virus antibodies, Hepatitis delta total antibodies
Useful when determining whether a patient has been previously exposed to herpes simplex virus (HSV) types 1 and 2.
Serum
SST (1)
None
None
Allow SST to clot for at least 15 minutes post-draw. As soon as possible, spin collection tube for 15 minutes to seperate plasma from red cells. Using a pipette, aliquot all available plasma into a plastic transport vial and freeze.
Useful for direct detection and differentiation of HSV-1 and HSV-2 DNA in various specimen types from symptomatic patients. It aids in the diagnosis of HSV infection in symptomatic patients.
Varies
VARIES (1)
None
None
Specimen source required (see site link for additional information).
REFRIGERATE (7 Days)
4 Days
Real-Time PCR
87529 x2
HSV PCR, HSV (Herpes Simplex Virus) by PCR (Polymerase Chain Reaction), Herpes Simplex Virus Detection by Real-Time PCR
Used as a marker for methylation status, and to determine the presence of histadelia or histapenia. Utilized as an accurate marker for under methylation or over methylation
Useful in the confirmation and differentiation of HIV-1 and HIV-2 antibodies in plasma specimens that show reactive results with third-(HIV-1/-2 antibody only) and fourth-generation (HIV antigen and antibody) HIV serologic assays. This test is not useful as a screening test for HIV infection in symptomatic or asymptomatic individuals. It is not to be used as a screening or confirmatory test for blood donor specimens.
Plasma
EDTA (1)
Plastic Transport Vial
1 mL (0.8 mL Minimum)
None
None
Gently invert tube at least 10 times post-collection. Centrifuge and seperate plasma from cells within 2 hours of collection. Aliquot plasma into plastic transport vial and freeze.
Centrifuge and seperate plasma within 2 hours of collection.
Useful for determining HIV genotype to guide antiviral therapy and for differentiating between HIV subtypes. Should not be used as a screening test for HIV infection.
Plasma
EDTA (2)
Original Collection Vial(s)
5.0 mL (1.6 mL Minimum)
None
None
Gently invert the tube at least 10 times post-collection. Submit unopened collection tube.
Useful for diagnosis of HIV-1 infection in individuals with acute or early HIV-1 infection, and for diagnosis of HIV-1 infection in infants under 18 months of age born to mothers living with HIV-1.
Plasma
EDTA (2)
None
None
Pour off within 6 HR of collection. Send 3.0 mL plasma frozen. Dedicated specimen required.
Useful when determining whether a patient has been previously exposed to herpes simplex virus (HSV) types 1 and 2, and for distinguishing between infection caused by HSV types 1 and 2, especially in patients with subclinical or unrecognized HSV infection.